Versant Side
QuietMenlo Park, CAHealthcare, Biotechnology, PharmaceuticalsLast fund filed October 2001
9 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Versant Side Fund II, LP | October 2001 | $3.6M | $3.6M | 16 |
| VERSANT SIDE FUND I LP | 2000 | $5M | $5M | 18 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
9 partners are named across this firm’s filings, 9 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Barbara Lubash | Quiet | Healthcare services, Digital health | 4 | 0 |
Classified sectors of Versant Side’s own portfolio companies, based on 60 with a verified or cited source.
| Firm | Shared boards | Companies |
|---|---|---|
| Versant Venture Capital | 37 | 858 Therapeutics, AcuFocus, Alexza Pharmaceuticals, Allegro Ophthalmics, Alphaeon, ALTERG, BIRD ROCK BIO, Ceterix Orthopaedics, CRISPR Therapeutics AG, DocMatter, Edwards Lifesciences, Equinox Ophthalmic, FLUIDIGM, Inari Medical, Inception 5, Inception IBD, KINESTRAL TECHNOLOGIES, LENSAR, MINERVA SURGICAL, Monte Rosa Therapeutics, NEOVISTA, Neurolens, Northern Mosaic, Okami Medical, OneFocus Vision, Oyster Point Pharma, Prelude, Relievant MedSystems, RENNOVIA, RxSight, SECOND SIGHT MEDICAL PRODUCTS, Sequent Medical, Sympara Medical, TearClear, Tempest Therapeutics, VERACYTE, ViaLase |
| Versant Venture V AIV | 35 | 858 Therapeutics, AcuFocus, Alexza Pharmaceuticals, Allegro Ophthalmics, Alphaeon, BIRD ROCK BIO, Black Diamond Therapeutics, Ceterix Orthopaedics, CRISPR Therapeutics AG, Edwards Lifesciences, Equinox Ophthalmic, FLUIDIGM, Inari Medical, Inception 1, Inception 5, Inception IBD, KINESTRAL TECHNOLOGIES, LENSAR, Monte Rosa Therapeutics, NEOVISTA, Neurolens, Northern Mosaic, Okami Medical, OneFocus Vision, Oyster Point Pharma, Prelude, RENNOVIA, RxSight, SECOND SIGHT MEDICAL PRODUCTS, Sequent Medical, SIGHTLIFE SURGICAL, TearClear, Tempest Therapeutics, VERACYTE, ViaLase |
| Bradley Bolzon | Quiet | Biotech & pharma | 10 | 0 |
| Brian Atwood | Quiet | Biotech & pharma, Fintech | 8 | 0 |
| Charles Warden | Quiet | Medical devices, AI & machine learning, Biotech & pharma | 8 | 0 |
| Donald Milder | Quiet | Medical devices | 3 | 0 |
| Rebecca Robertson | Quiet | Medical devices, Digital health, Robotics & hardware | 5 | 0 |
| Ross Jaffe | Quiet | Medical devices, Digital health | 5 | 0 |
| Samuel Colella | Quiet | Biotech & pharma, Climate & energy, Manufacturing & industrials | 5 | 0 |
| William Link | Quiet | Medical devices, Biotech & pharma, Digital health | 16 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Versant Side’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Versant Voyageurs | 14 | 858 Therapeutics, BIRD ROCK BIO, Black Diamond Therapeutics, Ceterix Orthopaedics, CRISPR Therapeutics AG, Inari Medical, Inception 5, Inception IBD, Monte Rosa Therapeutics, Northern Mosaic, Okami Medical, Oyster Point Pharma, Sequent Medical, Tempest Therapeutics |
| Versant Vantage | 10 | 858 Therapeutics, BIRD ROCK BIO, Black Diamond Therapeutics, CRISPR Therapeutics AG, Inception 5, Inception IBD, Monte Rosa Therapeutics, Northern Mosaic, Oyster Point Pharma, Tempest Therapeutics |
| U.S Venture Partners | 5 | Inari Medical, Intuity Medical, Okami Medical, Sequent Medical, ViaLase |
| Domain Partners | 3 | Cotera, Sequent Medical, TWELVE |
| Stack Infrastructure | 3 | Inari Medical, Okami Medical, Sequent Medical |
| Westlake Biopartners | 3 | Cell Design Labs, Ceterix Orthopaedics, REDBRICK HEALTH |
| Lightstone Ventures | 2 | GLUMETRICS, TWELVE |
| Qiming U.S Healthcare | 2 | FIVE PRIME THERAPEUTICS, TWELVE |
| Vida Ventures | 2 | Cell Design Labs, VERACYTE |
| Amzl | 1 | CRISPR Therapeutics AG |
| ARCH Venture Partners | 1 | PHASERX |
| Longitude Capital | 1 | Ceribell |
| New Enterprise Associates | 1 | Ceterix Orthopaedics |
A shared board seat: a company where filings name a Versant Side partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.